Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma

Stopped Withdrawn: study halted prematurely, prior to enrollment of first participant

Conditions

• Optic Nerve Glioma

Interventions

• DRUG: Temozolomide
• DRUG: ANP Therapy

Sponsor

Burzynski Research Institute